All In MedTech

Company

Johnson & Johnson MedTech

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

Johnson & Johnson MedTech is on our public-company list (ticker JNJ). Names searched as well: Ethicon, DePuy, Biosense Webster, Abiomed. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

JNJ

NYSE · JOHNSON & JOHNSON

Public float

$367.0B

Value of shares held by non-insiders on Jun 29, 2025

Revenue

$94.2B

Fiscal year ending Dec 28, 2025

Net income

$26.8B

Fiscal year ending Dec 28, 2025

R&D spending

$109M

Fiscal year ending Dec 28, 2025

Cash

$16.9B

As of Sep 27, 2026

Long-term debt

$35.8B

As of Sep 27, 2026

Shares outstanding

2407.3M

As of Oct 15, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2025––$9.14B–
2024––$6.66B–
2023$4.24B–––
2022––$5.0M–
2021––$7.43B–

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is free with an account

For Johnson & Johnson MedTech we have 1 shareholder with 5% or more and 64 government grants totalling $17.4M.

Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.

Latest FDA decisions

The 8 newest of 242 since 2015.

Search the Clearance Tracker

241 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • NCT07943182 · 60 participants (planned) · Start Dec 3, 2024 · Primary completion Dec 2027

    Device: Impella CP with SmartAssist; Impella 5.5 with SmartAssist · For: Cardiogenic Shock; Heart Failure; Acute Decompensated Heart Failure (ADHF) and 2 more

    Sites: Phoenix, Arizona; Loma Linda, California; Los Angeles, California · 24 sites in all

278 more trials with a free account

Reports received

69,080

Received Nov 1, 2025 to Nov 20, 2026. Includes 16 of another or unstated type.

Malfunction reports

43,297

63% of reports

Injury reports

23,182

34% of reports

Death reports

2,585

3.7% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 233,5251,354440
Jan 243,8591,532552
Feb 244,2911,906580
Mar 244,0452,9171190
Apr 244,0552,677470
May 243,6582,218732
Jun 243,8281,839812
Jul 243,8031,865491
Aug 244,1853,7706360
Sep 244,3411,8971070
Oct 244,9242,4873253
Nov 244,3892,1325120
Dec 243,6591,8201351
Jan 253,5281,5941270
Feb 252,7381,326970
Mar 253,0661,4201520
Apr 253,5071,8511680
May 253,5632,0691550
Jun 253,4832,4162190
Jul 253,9082,4001780
Aug 253,1711,3341050
Sep 253,7531,9932840
Oct 253,5141,8212320
Nov 252,8861,6151420
Dec 254,0591,9591840
Jan 263,9242,3923801
Feb 263,2152,5444710
Mar 263,5182,1893630
Apr 264,0992,1331850
May 263,2541,5321930
Jun 264,2951,6431910
Jul 263,4561,6431405
Aug 263,6531,95015410
Sep 263,7731,9251280
Oct 263,1651,657540
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

7 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

1,342 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.